Kuros Biosciences AG
CSBTF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $1,104,786 | $762,112 | $462,972 | $118,485 |
| - Cash | $17,896 | $17,460 | $14,277 | $14,208 |
| + Debt | $1,791 | $1,793 | $1,964 | $2,143 |
| Enterprise Value | $1,088,681 | $746,445 | $450,659 | $106,420 |
| Revenue | $63,480 | $43,711 | $31,844 | $20,698 |
| % Growth | 45.2% | 37.3% | 53.9% | – |
| Gross Profit | $56,332 | $33,664 | $28,367 | $17,424 |
| % Margin | 88.7% | 77% | 89.1% | 84.2% |
| EBITDA | $4,478 | -$956 | $395 | -$3,093 |
| % Margin | 7.1% | -2.2% | 1.2% | -14.9% |
| Net Income | -$2,013 | -$3,505 | -$211 | -$8,675 |
| % Margin | -3.2% | -8% | -0.7% | -41.9% |
| EPS Diluted | -0.051 | -0.094 | -0.006 | -0.24 |
| % Growth | 46.3% | -1,552.6% | 97.6% | – |
| Operating Cash Flow | -$2,677 | $3,456 | -$316 | -$2,099 |
| Capital Expenditures | -$1,068 | -$515 | -$597 | -$235 |
| Free Cash Flow | -$3,745 | $2,941 | -$913 | -$2,334 |